2 Stocks Riding the $100 Billion GLP-1 Weight-Loss Wave in India
The global obesity drug boom is minting winners in unexpected places. As pharma giants race to supply GLP-1 therapies, two Indian manufacturers one making the device, another building the molecule could quietly capture a slice of a $100 billion market.
The global obesity drug boom is minting winners in unexpected places. As pharma giants race to supply GLP-1 therapies, two Indian manufacturers one making the device, another building the molecule could quietly capture a slice of a $100 billion market.
What's Your Reaction?
:max_bytes(150000):strip_icc()/GettyImages-2187410260-5afe56694791404f99c253dd8d5abe6a.jpg?#)
